Kintara Therapeutics, Inc. (KTRA)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 0.1572 |
| Open | 0.1565 |
| Bid | 0.1502 x 1200 |
| Ask | 0.1544 x 4100 |
| Day's range | 0.1499 - 0.1624 |
| 52-week range | 0.0810 - 5.6000 |
| Volume | |
| Avg. volume | 15,059,983 |
| Market cap | 5.906M |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Kintara (KTRA) Stock Soars on Merger Agreement With TuHURA
Kintara (KTRA) inks a definitive merger agreement with TuHURA for an all-stock transaction. It is expected to close in the third quarter of 2024. The stock surges 63.4%.
- Zacks
Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy
Kintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its breast cancer treatment candidate, REM-001. The stock surges 41%.
© 2024 Yahoo. All rights reserved.